MOHAP License number: EL8FCWAY-150725
SKU : 67777
Ozempic Semaglutide 1mg Solution For Injection In Pre-Filled Pen
Ozempic is a prescription medicine indicated for the treatment of insufficiently controlled type 2 diabetes mellitus (in adults) as an adjunct to diet and exercise and also to reduce the risk of major adverse cardiovascular (CV) (heart related) events in adults with type 2 diabetes mellitus and established CV disease. Ozempic contains the active substance Semaglutide which is a glucagon-like peptide 1 (GLP-1) receptor agonist. Semaglutide works by binding to and activating the GLP-1 receptor, thereby stimulating insulin secretion and reducing blood glucose.
Ozempic® is used on its own – if your blood sugar is not controlled well enough by diet and exercise alone, and you cannot use it with metformin (another diabetes medicine) or with other medicines for diabetes – when they are not enough to control your blood sugar levels. These other medicines may include: oral antidiabetics (such as metformin, thiazolidinediones, sulfonylureas, sodium-glucose cotransporter 2 (SGLT2) inhibitor) or insulin.
The product description provided above is just a guideline and comes from the manufacturer or supplier. There can be a chance that some of the information might be incomplete or not entirely accurate. So, it is recommended to use this description as a guide, but make sure to check the detailed information once you have the product in hand. This includes information like description, benefits, usage instruction, any possible side effects, the ingredients, and any specific guidelines or warnings. If you have any questions or concerns about the product, feel free to reach out to one of our pharmacists in-store or give us a call at 800BINSINA for more assistance.
This medicine is not an insulin and should not be used if: you have type 1 diabetes - a condition where your body does not produce any insulin or you develop diabetic ketoacidosis. |Boxed Warning from FDA: In rodents, Semaglutide causes thyroid C-cell tumors. It is unknown whether OZEMPIC® causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as the human relevance of Semaglutide-induced rodent thyroid C-cell tumors has not been determined. OZEMPIC® is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk of MTC and symptoms of thyroid tumors. |Contraindicated if you have personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2. Tell your doctor if you have a personal or family history of thyroid cancer or Multiple Endocrine Neoplasia (MEN) syndrome. | Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Use this medicine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. |Your doctor will know the dose that is right for you as the dose can be affected by various factors such as age, severity of the condition, comorbidities and concomitant drugs you take. So, this drug should not be administered without proper advice from your doctor. |It is not known if OZEMPIC can be used in people who have had pancreatitis. OZEMPIC is not for use in people with type 1 diabetes. |Most common adverse reactions: nausea, vomiting, diarrhea, abdominal pain and constipation. Serious side effects, includes inflammation of the pancreas (pancreatitis), low blood sugar (hypoglycemia), diabetic retinopathy complications, acute kidney injury, hypersensitivity reactions, acute gallbladder disease. |Read the information leaflet thoroughly to know important dosage and administration instructions. Never share an OZEMPIC® pen between patients, even if the needle is changed.
Used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus |To reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease |Used as monotherapy when metformin is not tolerated or contraindicated